Related Experiment Video
Updated: Jul 30, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Current state and practice variation in the use of Meningitis/Encephalitis (ME) FilmArray panel in children
Prabi Rajbhandari1, Nathaniel Goodrich2, Aleisha M Nabower3
1Akron Children's Hospital, One Perkins Square, Akron, OH, USA.
Insights
The Meningitis/Encephalitis FilmArray® Panel (ME panel) is widely used, but most providers lack institutional guidelines for its use and interpretation. Educational initiatives are needed to improve understanding and application of ME panel results.
Area of Science:
- Pediatric infectious diseases
- Clinical diagnostics
- Molecular testing
Background:
- The Meningitis/Encephalitis FilmArray® Panel (ME panel) offers rapid diagnostics for suspected meningitis or encephalitis.
- Evaluation of these patients involves multiple pediatric subspecialties, including hospital medicine, emergency medicine, infectious diseases, and intensive care.
Purpose of the Study:
- To assess the current utilization of the ME panel across different pediatric subspecialties.
- To identify variations in provider practices and institutional guidelines regarding ME panel use.
Main Methods:
- An online cross-sectional survey was distributed to pediatric subspecialty listservs.
- The survey targeted physicians in pediatric hospital medicine, emergency medicine, and pediatric intensive care.
Main Results:
- 68% of respondents reported current use of the ME panel.
- A significant majority (75-76%) lacked institutional guidelines for test indications and interpretation.
- Providers with institutional guidelines demonstrated higher knowledge of the ME panel's performance characteristics.
Conclusions:
- Widespread adoption of the ME panel contrasts with a lack of standardized institutional guidelines.
- There is a clear need for enhanced education and guidance on ME panel indications and interpretation for pediatric subspecialists.
Background:
The Meningitis/Encephalitis FilmArray® Panel (ME panel) was approved by the U.S. Food and Drug Administration in 2015 and provides rapid results when assessing patients with suspected meningitis or encephalitis. These patients are evaluated by various subspecialties including pediatric hospital medicine (PHM), pediatric emergency medicine (PEM), pediatric infectious diseases, and pediatric intensive care unit (PICU) physicians. The objective of this study was to evaluate the current use of the ME panel and describe the provider and subspecialty practice variation.
Methods:
We conducted an online cross-sectional survey via the American Academy of Pediatrics Section of Hospital Medicine (AAP-SOHM) ListServe, Brown University PEM ListServe, and PICU Virtual pediatric system (VPS) Listserve.
Results:
A total of 335 participants out of an estimated 6998 ListServe subscribers responded to the survey. 68% reported currently using the ME panel at their institutions. Among test users, most reported not having institutional guidelines on test indications (75%) or interpretation (76%). 58% of providers self-reported lack of knowledge of the test's performance characteristics. Providers from institutions that have established guidelines reported higher knowledge compared to those that did not (51% vs. 38%; p = 0.01). More PHM providers reported awareness of ME panel performance characteristics compared to PEM physicians (48% vs. 27%; p = 0.004); confidence in test interpretation was similar between both groups (72 vs. 69%; p = 0.80).
Conclusion:
Despite the widespread use of the ME panel, few providers report having institutional guidelines on test indications or interpretation. There is an opportunity to provide knowledge and guidance about the ME panel among various pediatric subspecialties.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

